For the full year of 2023, operating expenses were $111,700,000 compared to $123,800,000 for the full year of 2022 and adjusted operating expenses for the full year of 2023 were 98 $900,000 compared to $103,200,000 for the full year 2022. The takeaway from our year over year reduction of adjusted operating expenses is that as a company, we have spent significant effort over the last year rightsizing our spend, while also accelerating innovative product releases as demonstrated by our Version 2 kit and funding a large part of our scaling our commercial operations. Net loss for the Q4 of 2023 was $22,000,000 compared to $33,100,000 in the Q4 of 2022 and adjusted EBITDA for the Q4 of 2023 was negative $25,100,000 compared to negative $24,500,000 in the Q4 of 20 $1,000,000 compared to $132,400,000 in 2022 and adjusted EBITDA for 2023 was negative $94,300,000 dollars compared to negative $100,600,000 for 2022. As of December 31, 2023, we had $257,700,000 in cash and cash equivalents and investments in marketable securities. Our full commercial launch plan includes a main focus of a direct sales channel approach in the United States market and a combination of direct and distributor approach in EMEA.